Glowing puzzle piece fitting into puzzle
Biotech

Gilead pays $3.1B for Tubulis to bolster oncology ADC pipeline

Gilead has struck a deal to buy Tubulis for $3.15 billion upfront, securing an ADC candidate that is racing toward pivotal trials.
Nick Paul Taylor Apr 7, 2026 8:30am
Sanofi headquarters Sanofi

Sanofi bispecific sees respiratory ph. 2 wins, eczema fail

Apr 7, 2026 4:10am
Makary
Favicon Fierce Pharma

FDA's Makary shares policy requests with Congress

Apr 7, 2026 11:04am
Test tube pipette

CRO Fortrea launches AI solution to improve trial efficiency

Apr 7, 2026 11:01am
colorful brain art model

Lilly pays AC Immune $12.5M to expand Alzheimer’s collab

Apr 7, 2026 9:30am
Link

Biogen links up with Alloy platform to boost ASO drug development

Apr 7, 2026 6:00am
More News

AI model designs new treatment candidate for opioid addiction

Apr 6, 2026 3:00pm

Takeda tears up Denali partnership, returning dementia asset

Apr 6, 2026 1:50pm

Anthropic acquires stealth startup Coefficient Bio: reports

Apr 6, 2026 11:07am

Zeto’s EEG device gets FDA 510(k) clearance for outpatient use

Apr 6, 2026 10:44am